Lunai Bioworks (LNAI) Change in Cash (2011 - 2026)
Lunai Bioworks (LNAI) recorded quarterly Change in Cash of $2.7 million in Q1 2026, up 2100.28% quarter-over-quarter from -$133163.0 in Q4 2025, and up 335.78% on a YoY basis from $611238.0 in Q1 2025.
Lunai Bioworks (LNAI) Change in Cash (2011 - 2026) Analysis & Trends
Lunai Bioworks' Change in Cash history runs 16 years deep, the most recent figure standing at $2.7 million for Q1 2026.
- In Q1 2026, Change in Cash rose 335.78% year-over-year to $2.7 million; the TTM figure through Mar 2026 stood at $2.2 million (up 265.76% YoY), while the FY2025 annual figure was -$127767.0, up 92.28% from the prior year.
- Change in Cash was $2.7 million for Q1 2026 at Lunai Bioworks, up from -$133163.0 in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $2.7 million in Q1 2026 to a low of -$3.9 million in Q4 2022.
- Historically, Change in Cash has averaged -$620743.2 across 5 years, with a median of -$279494.0 in 2023.
- Biggest YoY gain for Change in Cash was 511542.31% in 2025; the steepest drop was 800.25% in 2025.
- A 5-year view of Change in Cash shows it stood at -$3.9 million in 2022, then surged by 92.75% to -$279494.0 in 2023, then surged by 132.63% to $91193.0 in 2024, then slumped by 246.02% to -$133163.0 in 2025, then jumped by 2100.28% to $2.7 million in 2026.
- The last three Change in Cash figures came in at $2.7 million (Q1 2026), -$133163.0 (Q4 2025), and $532108.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -45.97 Mn |
| 10 | Lunai Bioworks | 95.85 Mn | 92.70 Mn | 20,942.00 | 2.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.66 Mn |
| Dec 31, 2025 | -133,163.00 |
| Sep 30, 2025 | 532,108.00 |
| Jun 30, 2025 | -830,302.00 |
| Mar 31, 2025 | 611,238.00 |
| Dec 31, 2024 | 91,193.00 |
| Sep 30, 2024 | 104.00 |
| Jun 30, 2024 | -92,230.00 |
| Mar 31, 2024 | 68,717.00 |
| Dec 31, 2023 | -279,494.00 |
| Sep 30, 2023 | -1.35 Mn |
| Jun 30, 2023 | -1.07 Mn |
| Mar 31, 2023 | -1.17 Mn |
| Dec 31, 2022 | -3.85 Mn |
| Sep 30, 2022 | -1.20 Mn |
| Jun 30, 2022 | -1.98 Mn |
| Mar 31, 2022 | -2.56 Mn |
| Dec 31, 2021 | -1.67 Mn |
| Sep 30, 2021 | -5.29 Mn |
| Jun 30, 2021 | 16.14 Mn |